{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:34:57Z","timestamp":1787160897610,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031935","name":"Xi'an Jiaotong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031934","name":"First Affiliated Hospital of Xi'an Jiaotong University","doi-asserted-by":"publisher","award":["2025-QN-25"],"award-info":[{"award-number":["2025-QN-25"]}],"id":[{"id":"10.13039\/100031934","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijbiomac.2026.153436","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:38:57Z","timestamp":1783528737000},"page":"153436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cullin 3\/Kelch-like protein 18 promote ferroptosis and inhibit hepatocellular carcinoma progression through ubiquitination and degradation of glutathione peroxidase 4"],"prefix":"10.1016","volume":"374","author":[{"given":"Bingyi","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153436_bb0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","article-title":"Hepatocellular carcinoma: signaling pathways and therapeutic advances","volume":"10","author":"Zheng","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.153436_bb0010","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.23.02745","article-title":"Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline update","volume":"42","author":"Gordan","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153436_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153436_bb0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","article-title":"Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers","volume":"42","author":"Wang","year":"2023","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153436_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.iliver.2024.100083","article-title":"Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma","volume":"3","author":"Wang","year":"2024","journal-title":"Iliver"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153436_bb0030","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153436_bb0035","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/HEP.0000000000000390","article-title":"Ferroptosis in hepatocellular carcinoma: from bench to bedside","volume":"80","author":"Tang","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2026.153436_bb0040","article-title":"System X(c) (\u2212)\/GSH\/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.153436_bb0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/cr.2016.39","article-title":"Ubiquitin modifications","volume":"26","author":"Swatek","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.ijbiomac.2026.153436_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116270","article-title":"Targeting kelch-like (KLHL) proteins: achievements, challenges and perspectives","volume":"269","author":"Zhou","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153436_bb0055","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1038\/s41467-024-45796-w","article-title":"MYC induces CDK4\/6 inhibitors resistance by promoting pRB1 degradation","volume":"15","author":"Ma","year":"2024","journal-title":"Nat. Commun."},{"issue":"47","key":"10.1016\/j.ijbiomac.2026.153436_bb0060","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1038\/s41388-023-02858-5","article-title":"KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer","volume":"42","author":"Yao","year":"2023","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153436_bb0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13578-020-00499-9","article-title":"KLHL18 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by inhibiting PI3K\/PD-L1 axis activity","volume":"10","author":"Jiang","year":"2020","journal-title":"Cell Biosci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.153436_bb0070","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","article-title":"GPX4 in cell death, autophagy, and disease","volume":"19","author":"Xie","year":"2023","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.153436_bb0075","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41556-025-01610-3","article-title":"PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer","volume":"27","author":"Fan","year":"2025","journal-title":"Nat. Cell Biol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.153436_bb0080","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41419-023-06222-z","article-title":"The E3 ligase TRIM26 suppresses ferroptosis through catalyzing K63-linked ubiquitination of GPX4 in glioma","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153436_bb0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","article-title":"CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1","volume":"42","author":"Li","year":"2023","journal-title":"Oncogene"},{"issue":"23","key":"10.1016\/j.ijbiomac.2026.153436_bb0090","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018101409","article-title":"Cul3-Klhl18 ubiquitin ligase modulates rod transducin translocation during light-dark adaptation","volume":"38","author":"Chaya","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2026.153436_bb0095","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920927602","article-title":"Is the era of sorafenib over? A review of the literature","volume":"12","author":"Fan","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.153436_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175913","article-title":"Understanding sorafenib-induced ferroptosis and resistance mechanisms: implications for cancer therapy","volume":"955","author":"Li","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153436_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13045-020-00885-3","article-title":"Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy","volume":"13","author":"Li","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153436_bb0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","article-title":"Targeted protein degradation: mechanisms, strategies and application","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026033817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026033817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:39:56Z","timestamp":1787157596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026033817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":22,"alternative-id":["S0141813026033817"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153436","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cullin 3\/Kelch-like protein 18 promote ferroptosis and inhibit hepatocellular carcinoma progression through ubiquitination and degradation of glutathione peroxidase 4","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"153436"}}